Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Homocysteine effects on brain volumes mapped in 732 elderly individuals.

Rajagopalan P, Hua X, Toga AW, Jack CR Jr, Weiner MW, Thompson PM.

Neuroreport. 2011 Jun 11;22(8):391-5. doi: 10.1097/WNR.0b013e328346bf85.

2.

Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.

Madsen SK, Rajagopalan P, Joshi SH, Toga AW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurobiol Aging. 2015 Jan;36 Suppl 1:S203-10. doi: 10.1016/j.neurobiolaging.2014.01.154. Epub 2014 Aug 30.

3.

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.

Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H.

PLoS One. 2010 Sep 8;5(9):e12244. doi: 10.1371/journal.pone.0012244.

4.

Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study.

Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, Ward V, Ames D, Masters CL, Bush AI.

J Alzheimers Dis. 2011;27(4):909-22. doi: 10.3233/JAD-2011-110752.

PMID:
21891867
5.

Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults.

Feng L, Isaac V, Sim S, Ng TP, Krishnan KR, Chee MW.

Am J Geriatr Psychiatry. 2013 Feb;21(2):164-72. doi: 10.1016/j.jagp.2012.10.017. Epub 2013 Jan 22.

PMID:
23343490
6.

Homocysteine and brain atrophy on MRI of non-demented elderly.

den Heijer T, Vermeer SE, Clarke R, Oudkerk M, Koudstaal PJ, Hofman A, Breteler MM.

Brain. 2003 Jan;126(Pt 1):170-5.

PMID:
12477704
7.

3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry.

Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR Jr, Bernstein MA, Britson PJ, Ward CP, Whitwell JL, Borowski B, Fleisher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2008 May 15;41(1):19-34. doi: 10.1016/j.neuroimage.2008.02.010. Epub 2008 Feb 21.

8.

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.

Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P.

Neurobiol Aging. 2008 Jan;29(1):1-11. Epub 2006 Oct 19.

PMID:
17055615
9.

Serum folate, homocysteine, brain atrophy, and auto-CM system: The Treviso Dementia (TREDEM) study.

Gallucci M, Zanardo A, Bendini M, Di Paola F, Boldrini P, Grossi E.

J Alzheimers Dis. 2014;38(3):581-7. doi: 10.3233/JAD-130956.

PMID:
24028866
10.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

11.

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

Davatzikos C, Xu F, An Y, Fan Y, Resnick SM.

Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.

12.

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Brain. 2007 Jul;130(Pt 7):1777-86. Epub 2007 May 28.

13.

Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey.

Kim G, Kim H, Kim KN, Son JI, Kim SY, Tamura T, Chang N.

J Alzheimers Dis. 2013;33(3):853-62. doi: 10.3233/JAD-2012-121345.

PMID:
23042212
14.

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ; Alzheimer Disease Cooperative Study.

JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774.

15.

Critical levels of brain atrophy associated with homocysteine and cognitive decline.

de Jager CA.

Neurobiol Aging. 2014 Sep;35 Suppl 2:S35-9. doi: 10.1016/j.neurobiolaging.2014.03.040. Epub 2014 May 15. Review.

16.

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.

Douaud G, Refsum H, de Jager CA, Jacoby R, Nichols TE, Smith SM, Smith AD.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9523-8. doi: 10.1073/pnas.1301816110. Epub 2013 May 20.

17.

A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly.

Ellinson M, Thomas J, Patterson A.

J Hum Nutr Diet. 2004 Aug;17(4):371-83; quiz 385-7. Review.

PMID:
15250847
18.

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A.

Brain. 2012 Jan;135(Pt 1):170-80. doi: 10.1093/brain/awr277. Epub 2011 Nov 21.

19.

Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2009 Sep;30(9):2766-88. doi: 10.1002/hbm.20708.

20.

Automatic morphometry in Alzheimer's disease and mild cognitive impairment.

Heckemann RA, Keihaninejad S, Aljabar P, Gray KR, Nielsen C, Rueckert D, Hajnal JV, Hammers A; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Jun 15;56(4):2024-37. doi: 10.1016/j.neuroimage.2011.03.014. Epub 2011 Mar 11.

Supplemental Content

Support Center